Jindal Saw Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 5, 2025, 3:58 am

Competitors of Jindal Saw Ltd

All Competitor Stocks of Jindal Saw Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:35 am

Below is a detailed analysis of the quarterly data for Jindal Saw Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 4,085.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,047.00 Cr. (Mar 2025) to 4,085.00 Cr., marking a decrease of 962.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,415.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4,310.00 Cr. (Mar 2025) to 3,415.00 Cr., marking a decrease of 895.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 670.00 Cr.. The value appears to be declining and may need further review. It has decreased from 736.00 Cr. (Mar 2025) to 670.00 Cr., marking a decrease of 66.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 16.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 171.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 139.00 Cr. (Mar 2025) to 171.00 Cr., marking an increase of 32.00 Cr..
• For Depreciation, as of Jun 2025, the value is 153.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 153.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 374.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 99.00 Cr..
• For Tax %, as of Jun 2025, the value is -11.00%. The value appears to be improving (decreasing) as expected. It has decreased from 82.00% (Mar 2025) to -11.00%, marking a decrease of 93.00%.
• For Net Profit, as of Jun 2025, the value is 415.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 415.00 Cr., marking an increase of 328.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.63. The value appears strong and on an upward trend. It has increased from 4.55 (Mar 2025) to 6.63, marking an increase of 2.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:03 am

Growth

Last Updated: September 5, 2025, 8:20 am

Balance Sheet

Last Updated: June 16, 2025, 11:53 am

Below is a detailed analysis of the balance sheet data for Jindal Saw Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 64.00 Cr..
• For Reserves, as of Mar 2025, the value is 11,347.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,029.00 Cr. (Mar 2024) to 11,347.00 Cr., marking an increase of 1,318.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,859.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5,761.00 Cr. (Mar 2024) to 4,859.00 Cr., marking a decrease of 902.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,395.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,824.00 Cr. (Mar 2024) to 4,395.00 Cr., marking a decrease of 429.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 20,665.00 Cr.. The value appears to be improving (decreasing). It has decreased from 20,679.00 Cr. (Mar 2024) to 20,665.00 Cr., marking a decrease of 14.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 9,341.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,853.00 Cr. (Mar 2024) to 9,341.00 Cr., marking an increase of 488.00 Cr..
• For CWIP, as of Mar 2025, the value is 641.00 Cr.. The value appears strong and on an upward trend. It has increased from 632.00 Cr. (Mar 2024) to 641.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 168.00 Cr.. The value appears to be declining and may need further review. It has decreased from 178.00 Cr. (Mar 2024) to 168.00 Cr., marking a decrease of 10.00 Cr..
• For Other Assets, as of Mar 2025, the value is 10,516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11,016.00 Cr. (Mar 2024) to 10,516.00 Cr., marking a decrease of 500.00 Cr..
• For Total Assets, as of Mar 2025, the value is 20,665.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,679.00 Cr. (Mar 2024) to 20,665.00 Cr., marking a decrease of 14.00 Cr..

Notably, the Reserves (11,347.00 Cr.) exceed the Borrowings (4,859.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Jindal Saw Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 2.00 (Mar 24) to 1.00, marking a decrease of 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 27.31. This value is within the healthy range. It has decreased from 52.75 (Mar 24) to 27.31, marking a decrease of 25.44.
• For Diluted EPS (Rs.), as of Mar 25, the value is 27.22. This value is within the healthy range. It has decreased from 52.68 (Mar 24) to 27.22, marking a decrease of 25.46.
• For Cash EPS (Rs.), as of Mar 25, the value is 31.80. This value is within the healthy range. It has decreased from 67.60 (Mar 24) to 31.80, marking a decrease of 35.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 178.43. It has decreased from 292.94 (Mar 24) to 178.43, marking a decrease of 114.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 178.43. It has decreased from 292.94 (Mar 24) to 178.43, marking a decrease of 114.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 325.70. It has decreased from 655.42 (Mar 24) to 325.70, marking a decrease of 329.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 55.48. This value is within the healthy range. It has decreased from 109.12 (Mar 24) to 55.48, marking a decrease of 53.64.
• For PBIT / Share (Rs.), as of Mar 25, the value is 46.07. This value is within the healthy range. It has decreased from 91.36 (Mar 24) to 46.07, marking a decrease of 45.29.
• For PBT / Share (Rs.), as of Mar 25, the value is 36.32. This value is within the healthy range. It has decreased from 69.32 (Mar 24) to 36.32, marking a decrease of 33.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 22.39. This value is within the healthy range. It has decreased from 49.84 (Mar 24) to 22.39, marking a decrease of 27.45.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 27.18. This value is within the healthy range. It has decreased from 52.45 (Mar 24) to 27.18, marking a decrease of 25.27.
• For PBDIT Margin (%), as of Mar 25, the value is 17.03. This value is within the healthy range. It has increased from 16.64 (Mar 24) to 17.03, marking an increase of 0.39.
• For PBIT Margin (%), as of Mar 25, the value is 14.14. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 14.14, marking an increase of 0.21.
• For PBT Margin (%), as of Mar 25, the value is 11.15. This value is within the healthy range. It has increased from 10.57 (Mar 24) to 11.15, marking an increase of 0.58.
• For Net Profit Margin (%), as of Mar 25, the value is 6.87. This value is within the healthy range. It has decreased from 7.60 (Mar 24) to 6.87, marking a decrease of 0.73.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.34. This value is within the healthy range. It has increased from 8.00 (Mar 24) to 8.34, marking an increase of 0.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.23. This value is within the healthy range. It has decreased from 16.61 (Mar 24) to 15.23, marking a decrease of 1.38.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.35. This value is within the healthy range. It has decreased from 23.00 (Mar 24) to 21.35, marking a decrease of 1.65.
• For Return On Assets (%), as of Mar 25, the value is 8.36. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 8.36, marking an increase of 0.39.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 24) to 0.13, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.55 (Mar 24) to 0.40, marking a decrease of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has decreased from 1.07 (Mar 24) to 0.99, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 1.5. It has increased from 1.24 (Mar 24) to 1.45, marking an increase of 0.21.
• For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.74, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 4. It has decreased from 2.81 (Mar 24) to 2.38, marking a decrease of 0.43.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.32. This value is below the healthy minimum of 20. It has increased from 5.68 (Mar 24) to 7.32, marking an increase of 1.64.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.43. This value is below the healthy minimum of 20. It has increased from 4.24 (Mar 24) to 5.43, marking an increase of 1.19.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.68. This value exceeds the healthy maximum of 70. It has decreased from 94.32 (Mar 24) to 92.68, marking a decrease of 1.64.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.57. This value exceeds the healthy maximum of 70. It has decreased from 95.76 (Mar 24) to 94.57, marking a decrease of 1.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.69. This value is within the healthy range. It has increased from 4.95 (Mar 24) to 5.69, marking an increase of 0.74.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.30. This value is within the healthy range. It has increased from 3.26 (Mar 24) to 3.30, marking an increase of 0.04.
• For Enterprise Value (Cr.), as of Mar 25, the value is 20,692.01. It has increased from 17,782.55 (Mar 24) to 20,692.01, marking an increase of 2,909.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has increased from 0.84 (Mar 24) to 0.99, marking an increase of 0.15.
• For EV / EBITDA (X), as of Mar 25, the value is 5.83. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 5.83, marking an increase of 0.73.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.82, marking an increase of 0.17.
• For Retention Ratios (%), as of Mar 25, the value is 92.67. This value exceeds the healthy maximum of 70. It has decreased from 94.31 (Mar 24) to 92.67, marking a decrease of 1.64.
• For Price / BV (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 1.51, marking an increase of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.82, marking an increase of 0.17.
• For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.10, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness